NatWest Group plc - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 206 filers reported holding PDL BIOPHARMA INC in Q4 2015. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.

Quarter-by-quarter ownership
NatWest Group plc ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2015$458,000
-28.5%
91,0690.0%0.01%
+25.0%
Q1 2015$641,000
+17.6%
91,069
+28.9%
0.01%
+60.0%
Q4 2014$545,000
+101.9%
70,625
+95.1%
0.01%
+150.0%
Q3 2014$270,000
-22.9%
36,2050.0%0.00%
-86.7%
Q2 2014$350,000
-8.4%
36,205
-21.3%
0.02%
-11.8%
Q1 2014$382,000
-4.7%
45,993
-3.2%
0.02%
+70.0%
Q4 2013$401,000
-21.4%
47,529
-25.8%
0.01%
-33.3%
Q3 2013$510,000
+12.1%
64,043
+8.7%
0.02%
+150.0%
Q2 2013$455,00058,9260.01%
Other shareholders
PDL BIOPHARMA INC shareholders Q4 2015
NameSharesValueWeighting ↓
HAYS ADVISORY LLC 1,037,600$6,672,0000.97%
Global X Management CO LLC 2,435,411$15,660,0000.86%
Advisors Asset Management, Inc. 5,373,113$34,549,0000.47%
Gotham Asset Management, LLC 7,233,838$46,514,0000.39%
TFS CAPITAL LLC 582,438$3,745,0000.37%
LOMBARDIA CAPITAL PARTNERS LLC 1,637,611$10,530,0000.36%
AMERICAFIRST CAPITAL MANAGEMENT, LLC 95,122$611,634,0000.33%
FIRST TRUST ADVISORS LP 17,536,793$112,762,0000.29%
Arrow Investment Advisors, LLC 214,595$1,380,0000.28%
GSA CAPITAL PARTNERS LLP 954,853$6,140,0000.24%
View complete list of PDL BIOPHARMA INC shareholders